Home > Food & Beverages > Food Additives > Flavor Enhancers > Psychedelic Mushroom Market

Psychedelic Mushroom Market Size

  • Report ID: GMI6886
  • Published Date: Oct 2023
  • Report Format: PDF

Psychedelic Mushroom Market Size

Psychedelic Mushroom Market size was valued at USD 1.93 billion in 2022 and it is estimated to register a CAGR of over 10.7% between 2023 and 2032. Extensive research has unveiled the potential therapeutic benefits of psilocybin, attracted investment and contributed to its mainstream acceptance.

 

The pressing mental health crisis has prompted a search for novel treatments, where psychedelics, including psychedelic mushrooms, are being explored as promising alternatives. As a result, investors, consumers, and entrepreneurs have shown a keen interest in this emerging sector, propelling its expansion.

 

The ever-evolving legal landscape can be a double-edged sword. While some regions are moving towards decriminalization or legalization, many areas still consider psychedelic mushrooms illegal, creating a patchwork of regulations that can be confusing and risky for businesses. Safety concerns are another pressing issue, as the recreational use of psychedelic mushrooms can lead to unpredictable and potentially harmful experiences, which can result in negative publicity and pose genuine risks to consumers.

Authors: Kunal Ahuja, Himanshu Kabra

Frequently Asked Questions (FAQ) :

The market size of psychedelic mushroom reached USD 1.93 billion in 2022 and is set to expand at over 10.7% CAGR from 2023 to 2032, led by the ongoing research to discover the potential therapeutic benefits.

The psilocybe product segment generated USD 1.70 billion in revenue in 2022, attributed to ongoing research initiatives along with the growing demand for alternative and holistic approaches to healthcare.

Asia Pacific market is projected to witness 10.1% CAGR through 2032, owing to the growing awareness and acceptance of the potential therapeutic benefits of psychedelics in the region.

Some of the leading psychedelic mushroom companies include Field Trip Health, Atai Life Sciences, Cybin Inc., Mydecine Innovations Group, Revive Therapeutics, and Numinus Wellness.

Psychedelic Mushroom Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 8
  • Tables & Figures: 264
  • Countries covered: 21
  • Pages: 180
 Download Free Sample